Group One Trading, L.P. Genocea Biosciences, Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.01 - $1.38 $505 - $69,713	-50,517 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.96 - $1.35 $6,242 - $8,779	6,503 Added 14.77%	50,517 $63,000
Q4 2021 Feb 11, 2022	SELL	$0.95 - $1.99 $16,720 - $35,024	-17,600 Reduced 28.56%	44,014 $51,000
Q3 2021 Nov 12, 2021	BUY	$1.74 - $2.33 $72,973 - $97,717	41,939 Added 213.16%	61,614 $118,000
Q2 2021 Aug 10, 2021	BUY	$2.06 - $2.82 $30,405 - $41,623	14,760 Added 300.31%	19,675 $46,000
Q1 2021 May 12, 2021	SELL	$2.35 - $4.01 $6,735 - $11,492	-2,866 Reduced 36.83%	4,915 $13,000
Q4 2020 Feb 10, 2021	SELL	$1.91 - $2.67 $12,388 - $17,317	-6,486 Reduced 45.46%	7,781 $19,000
Q3 2020 Nov 12, 2020	BUY	$1.81 - $5.53 $25,823 - $78,896	14,267 New	14,267 $33,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.